Cargando…
Cooperative oncogenic effect and cell signaling crosstalk of co-occurring HER2 and mutant PIK3CA in mammary epithelial cells
Though incidence of PI3K oncogenic mutation is prominent in breast cancer (20-30%), pharmacological targeting of this signaling pathway alone has failed to provide meaningful clinical benefit. To better understand and address this problem, we conducted genome-wide analysis to study the association o...
Autores principales: | Dong, Lun, Meng, Fanyan, Wu, Ling, Mitchell, Allison V., Block, C. James, Zhang, Bin, Craig, Douglas B., Jang, Hyejeong, Chen, Wei, Yang, Qifeng, Wu, Guojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592866/ https://www.ncbi.nlm.nih.gov/pubmed/28902361 http://dx.doi.org/10.3892/ijo.2017.4108 |
Ejemplares similares
-
Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC
por: Wu, Ling, et al.
Publicado: (2019) -
Mutant HER2 needs mutant HER3 to be an effective oncogene
por: Trenker, Raphael, et al.
Publicado: (2021) -
Reversing cancer stemness
por: Block, James, et al.
Publicado: (2015) -
Investigating the Structure and Dynamics of the PIK3CA Wild-Type and H1047R Oncogenic Mutant
por: Gkeka, Paraskevi, et al.
Publicado: (2014) -
Mutation of the PIK3CA oncogene in human cancers
por: Karakas, B, et al.
Publicado: (2006)